About
ImaginAb is a nuclear medicine company based in Los Angeles, California. Our mission is to transform cancer treatment via radioimmunotherapy and targeted molecular imaging. We engineer our proprietary antibody platform, radiolabeled minibodies and cys-diabodies, for theranostic applications aiming at biologically important targets in oncology and autoimmune diseases.